PR

Phani Ranjith Kumar Musunuru

Active Director Director DIN 10658874
DIN 10658874 First appointment Jun 2024 Primary industry Chemicals and Materials
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Phani Ranjith Kumar Musunuru

Data last updated:

Phani Ranjith Kumar Musunuru is a Director at Kamgo Pharma Chem Private Limited (since 2024). The company operates in Chemicals and Materials.

DIN 10658874
Primary Designation Director
Industry Chemicals and Materials
First Appointment 07 Jun 2024
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kamgo Pharma Chem Private Limited U24100TN2023PTC158172
Director07 Jun 20242023Active

Board colleagues of Phani Ranjith Kumar Musunuru

Directorship timeline

Open interactive timeline →
Kamgo Pharma Chem Private Limited
Premium access

Shareholding and investment profile for Phani Ranjith Kumar Musunuru

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Phani Ranjith Kumar Musunuru

Phani Ranjith Kumar Musunuru currently holds 1 directorship: Kamgo Pharma Chem Private Limited (Director, since 07 Jun 2024).

Phani Ranjith Kumar Musunuru was first appointed on 07 Jun 2024 as Director at Kamgo Pharma Chem Private Limited.

The current boards of Phani Ranjith Kumar Musunuru's companies include Kamali Gopinath (Kamgo Pharma Chem Private Limited), Vankadarigopinath (Kamgo Pharma Chem Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available